<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230423057977N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-20</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of  premature infant oral motor intervention by the mother on mothers' mood</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of Premature Infant Oromotor Intervention by mother on the situation of mood in mothers of premature infants</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>74</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69736</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Two hospitals of Al-Zahra and 17 of Shahrivar were selected by lottery to collect samples for the control and intervention groups, Blinding description: In order to prevent the exchange of information between the mothers of the two control and intervention groups, from the two hospitals of 17 Shahrivar and Al-Zahra Rasht, one control group and the other intervention group will be collected by lottery. The intervention group is selected from 17 Shahrivar Hospital in Rasht and the control group is selected from Al-Zahra Hospital.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Mood.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The mood questionnaire will be filled in at the beginning of the study by the mother, who both herself and her baby meet the inclusion criteria. And oral motor intervention of the premature baby is taught to the mother by the researcher on the doll and educational videos. Then, after appropriate feedback, this intervention will be performed by the mother on her baby under the supervision of the researcher and speech therapy for 10 days. And the mood questionnaire will be completed again by the mother after 10 days of intervention. Intervention 2: Control group: The mood questionnaire will be completed at the beginning of the study by mothers who both themselves and their babies meet the entry criteria. And 10 days later, this questionnaire is filled again by mothers. During these 10 days, the baby will be cared for according to the department's routine.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I have to make my final decision about publishing the data files in consultation with the supervisor.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sahar Hosseinzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NICU, Dr Pirooz hospital, Keshavarz Blvd</address>
        <city>Lahijan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>43111-44199</zip>
        <telephone>+98 21 4223 5503</telephone>
        <email>sahar.hosseinzadeh@ymail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sahar Hosseinzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NICU, Dr pirooz hospital, Keshavarz Blvd</address>
        <city>Lahijan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>43111-44199</zip>
        <telephone>+98 13 4223 5503</telephone>
        <email>sahar.hosseinzadeh@ymail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>For mothers, entry conditions include: no history of infertility
Uncomplicated pregnancy
Desire to be pregnant
No history of physical and mental illness
No addiction
Lack of accidents during the last three months (according to the participant)
The conditions for the inclusion of infants in the study include: 1) infants with a gestational age of 29-34 weeks, 2) having physiological stability and no stress symptoms at the time of stimulation, 3) without cleft palate, cleft lip, and temperament abnormalities, 4) infants with an Apgar score of 5 or more than 7</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Mother's unwillingness to continue participating in the study
Early discharge of the baby with the personal consent of the parents
Transferring the baby to another treatment center
Not having the ability to intervene
Incompleteness of 20% of the completed information of the forms
The conditions for the exclusion of infants from the study: 1) sepsis 2) heart disease 3) necrotizing enterocolitis 4) grade 3 and 4 intraventricular hemorrhage (according to sonography that is routinely performed in the first week) 5) severe asphyxia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The mood questionnaire will be filled in at the beginning of the study by the mother, who both herself and her baby meet the inclusion criteria. And oral motor intervention of the premature baby is taught to the mother by the researcher on the doll and educational videos. Then, after appropriate feedback, this intervention will be performed by the mother on her baby under the supervision of the researcher and speech therapy for 10 days. And the mood questionnaire will be completed again by the mother after 10 days of intervention.</i_keyword>
      <i_keyword>Control group: The mood questionnaire will be completed at the beginning of the study by mothers who both themselves and their babies meet the entry criteria. And 10 days later, this questionnaire is filled again by mothers. During these 10 days, the baby will be cared for according to the department's routine.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mood score in POMS standard questionnaire. Timepoint: Measuring the mood score at the beginning of the study (before the intervention) and 10 days after the intervention. Method of measurement: Standard Mood Questionnaire (POMS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Participation. Timepoint: The questionnaire will be filled at the beginning of the study and 10 days later. Method of measurement: Questionnaire POMS.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-16</approval_date>
        <contact_name>Working Group / Ethics Committee in Research Faculty of Nursing, Midwifery and Rehabilitation Facult</contact_name>
        <contact_address>Dr. Mirkhani St (East Nusrat), Tawheed Square Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
